Dupont De Nemours Inc (DD)

Investment Committee Summary

Investment Thesis

At $129 (13 October 2026) DuPont trades on 18x forward earnings, broadly the engine's base-case multiple. The market is pricing a durable mid-cycle: low-to-mid-single-digit organic growth, an operating margin around 15% (reported GAAP, TTM to Jun 2026), and no repeat of the raw-material squeezes that have punctuated prior cycles. The engine broadly agrees on earnings, since the probability-weighted value of $133 and the twelve-month target of $136 sit close to the market price, but the anchors disagree beneath the surface. Discounted cash flow, on a capital-to-depreciation bridge, lands well below spot, while the peer-median forward multiple implies a good deal more; the triangulated fair value of $118 leaves a gap of -9% to spot, so the shares are fairly valued against that anchor. Monte Carlo puts well under half the probability on fair value clearing the current price. HOLD follows directly: the shares are neither cheap against coatings and specialty peers nor supported by discounted cash flow, so there is no edge either way. The single most damaging risk is structural volume erosion combined with a raw-material squeeze, whose scenario target sits beneath the 52-week low.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($129) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The structural bear is not a cyclical wobble. DuPont is now a narrower specialty business with limited insulation against input costs. If capacity additions keep raw-material prices firm while construction and industrial volumes shrink, price increases stop sticking: the operating margin falls well below the current 15% (reported GAAP, TTM to Jun 2026) and does not mean-revert, because volume lost to cheaper substitutes is permanent rather than deferred demand. Earnings power resets lower and the market re-rates the shares as a commoditised cyclical rather than a specialty compounder, producing a value materially below the 52-week low. A balance sheet carrying net debt of ~$2.4B then constrains buybacks precisely when support is most needed, and the mechanism requires no recession, only that substitution proves durable and that pricing power, the single load-bearing assumption in the base case, turns out to have been a cycle rather than a franchise.

Key Debate

P/E Multiple explains 53% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

What the Market Is Pricing In

At the current price, the market pays 17.8× consensus forward EPS, vs the house DCF terminal 16.0×, and a peer median 22.8×. The house DCF sits 18% below spot, so the market is pricing in more than the house case — roughly 1.8pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — Brand / Volume Erosion' downside ($58.30) to a 'Bull — Cycle + Re-Rate' bull case ($238); the probability-weighted blend (PWEV $133) is +3% versus spot.

SBC charge: scenario targets are gross per-share prices; the PWEV is reduced by one year of stock-based-compensation dilution (1.5% of shares, on SBC ≈ 1% of revenue), trimming the gross PWEV of $135 to $133 (-1.5%). SBC is charged once, as dilution — never also deducted from FCF.

Scenario rationale — the driver path behind every target:

• Structural — Brand / Volume Erosion (20%, $58.30). Structural impairment — raw-material squeeze / volume loss: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
• Downturn — Construction / Industrial Slump (18%, $102). Cyclical downturn — specialty volumes + price/raw-material spread + specification lock-in weakens for 1–2 years before normalising.
• Base — Pricing-Led Compounding (33%, $139). Mid-cycle — normalised specialty volumes + price/raw-material spread + specification lock-in; disciplined capital allocation; steady returns.
• Growth — Share Gains + Mix (21%, $189). Upside — share gains + input deflation lifts earnings above mid-cycle; the multiple expands modestly.
• Bull — Cycle + Re-Rate (8%, $238). Upside tail — sustained tight conditions or a structural re-rate on share gains + input deflation.

Valuation Triangulation

Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the scenario PWEV, any DCF's exit-multiple terminal and any peer re-rate key off a market multiple, so they are not independent; only a DCF's explicit-period cash flows are multiple-free, and its terminal usually carries most of its value. The discipline is to read the spread, not to treat three numbers as three independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way. The company-lever row in the Sensitivity section is an illustrative EBIT × multiple value, not a sum-of-parts anchor.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $123 and 46% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (53% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

DCF — explicit-period cash flows with an exit-multiple terminal

A 5-year cash-flow path discounted at a WACC of 8.5%, plus a terminal value of final-year FCF × 16.0x — a terminal multiple equal to 0.85 × the base multiple that the Monte Carlo and the scenario tree also use → $106. The terminal value is 75% of enterprise value, so this anchor moves with the multiple assumption. The heaviest anchor in this blend (47%); because its terminal is a market multiple, it is not independent of the multiple-driven anchors.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $144; the peer-median forward P/E is 22.8x, but the engine carries no P/E-implied price for this name (fewer than three same-sub-industry peers carry a forward multiple). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.

Across all anchors the spread is 29% of the median — moderate (healthy method disagreement — read the blend with care).

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × model op-margin Δ (Δ applied to the DCF's house margin path)

Tornado — DCF/share swing by driver (widest first)

Company lever — value at the base multiple vs Specialty Chemicals & Formulated Materials multiple (base 19.0x)

Illustrative: segment EBIT × multiple, plus net cash, over basic shares — it does not enter the triangulated fair value.

Peer Quality & Weighting

Quality-weighted forward P/E: 19.1× (simple median 22.8×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $83.44–$157, centre $114 (-12% vs spot); spot sits at the 63rd percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio is (triangulated FV ÷ price − 1) ÷ (1 − 'Structural — Brand / Volume Erosion' target ÷ price). 'Structural — Brand / Volume Erosion' ($58.30, probability 20%) is the lowest-target scenario in the tree, taken gross of SBC dilution. With a leg missing the ratio is withheld rather than computed from a magnitude. Bull case (Bull — Cycle + Re-Rate): $238.

Company Overview & Business Model

Dupont De Nemours Inc — BASIC MATERIALS · SPECIALTY CHEMICALS. DuPont de Nemours, Inc., commonly known as DuPont, is an American company formed by the merger of Dow Chemical and E. I. du Pont de Nemours and Company on August 31, 2017, and the subsequent spinoffs of Dow Inc. and Corteva.

Company description as supplied by Alpha Vantage; not checked against the company's filings.

How it makes money.

† Model margin = gross margin − the opex ratio calibrated so the Monte Carlo median EPS meets the EPS target; it is not a reported operating margin.

Reported operating margin (GAAP): 12.6% for the fiscal year ended 2025-12-31; 14.7% TTM to 2026-06-30 (Alpha Vantage INCOME_STATEMENT).

Edge. Narrow moat — DuPont's edge is application-specific formulation know-how and qualified-in positions in semis (Kalrez, CMP slurries) and water (FilmTec membranes), not a broad chemical moat; that supports a modest premium to the commodity-chemical group but not much. If the moat is only narrow, the DCF terminal multiple should sit near 15-17x, not the ~19x forward the market pays; a compression toward the S&P chemicals median of ~16x is the falsifiable base case if electronics content growth stalls.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

For comparison, the company's reported GAAP operating margin was 12.6% for the fiscal year ended 2025-12-31; 14.7% TTM to 2026-06-30 (Alpha Vantage INCOME_STATEMENT).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue.

Competitive Moat

Moat sources:

• Qualified-in / spec-locked positions in semiconductor materials (CMP, photoresists, Kalrez) with multi-year requalification switching costs
• FilmTec reverse-osmosis membrane installed base and OEM specifications in water treatment
• Tyvek brand and process patents in protective materials
• Absence of a network or scale moat in coatings/specialty commoditizes much of the legacy portfolio

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.30 vs analyst floor +0.00 → delta +0.30 (n=31 mgmt / 25 Q&A; 25th pctile across the S&P book, z -0.8).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

News (last 365d, 1416 articles): avg ticker sentiment +0.15 (bullish 25% / bearish 7%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-11-01 (~20d) — Planned separation of the Electronics business (Qnity) completion / first standalone reporting (authored)
• 2026-11-03 (~22d) — Quarterly earnings — est. EPS $1.87 (AV EARNINGS_CALENDAR)
• 2027-02-15 (~126d) — Full-year 2026 results and initial 2027 organic-growth / margin framework (authored)

Forecast Track Record

• EPS surprise: beat 100% of the last 8 quarters; average surprise +10.3%.

Catalyst Timeline

6 catalysts in the next 90 days (of 14 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario-macro rows withheld pending re-authoring: 1 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 1 caution rules triggered of 5 evaluable (1 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is what the model's own rules read on this name; it does not modify the published research rating, and it is not personal financial advice.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Organic revenue growth, year-on-year < 0.015 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Operating margin < 0.163 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Free-cash-flow conversion of net income < 0.8 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Incremental legal/environmental (PFAS-related) charges, single announcement, $B > 0.5 (single event). A new charge above 0.5 billion dollars would add roughly a fifth to the existing 2.42 billion dollar net-debt position, cut buyback capacity and shift probability weight toward the structural scenario.
• Net debt / EBITDA > 2.75 (2 consecutive prints). Net debt of 2.42 billion dollars against roughly 1.18 billion dollars of EBITDA (EV 20.73 at EV/EBITDA 17.62) is about 2.1x today. A sustained move above 2.75x removes shareholder-return support and forces deleveraging at the cycle trough.

Fact / Inference / Speculation

• FACT: Spot $129; 52-week range $83.44–$157; engine rating HOLD; house target $136 (+5%). (source: Alpha Vantage 2026-10-12, 13 October 2026)
• INFERENCE: Triangulated FV $118 (-9% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the DCF anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

55.4/100 (confidence band 41.4–69.4), 39th percentile of 928 covered names (as of 2026-10-12). Weighted composite under config ros-1.21.0 — every component and its inputs below.

Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.

Score history: 54.9 → 55.1 → 55.5 → 55.6 → 55.4 → 55.3 → 55.7 → 55.3.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $134.73.

Factor Exposures

Cross-sectional percentiles over 928 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.57, vs QQQ +0.48 (trailing ~1y daily returns).

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies +3% vs spot
• Monte Carlo median implies -5% vs spot
• DCF fair value (exit-multiple terminal) implies -18% vs spot
• Bear case (Structural — Brand / Volume Erosion) downside is -55% vs spot
• Net: the valuation anchor itself sits 8.7% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.5% · Σ PV(FCF) $4B + PV(terminal) $13B = EV $17B; − net debt $2.4B → equity $14B ÷ diluted shares $0.14B = $106/share (exit-multiple terminal).

• Gordon terminal → $112/share — a single-point perpetual-growth cross-check at g = 2.5% (one growth rate, not a range; it is not in the blend).
• Incremental ROIC on the forecast capex ≈ 12% vs WACC 8.5% → above WACC — the build is value-creative.

Peer set

Implied prices at the peer medians: EV/Rev → $144 (no P/E-implied price — fewer than three same-sub-industry peers carry a forward multiple).

Weighted fair-value math

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Model op margin ±3pp (41.0); Revenue CAGR ±3pp (33.0); Terminal × ±15% (28.0); Capex intensity ±15% (13.0); WACC ±1pp (10.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

DCF: WACC 8.5%, terminal multiple 16×, FY+5 revenue $8B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.